Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.
Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas. Cancer Sci. 2022 Oct; 113(10):3535-3546.